Treatment of breast cancer 2 (BRCA2)-mutant follicular dendritic cell sarcoma with a poly ADP-ribose polymerase (PARP) inhibitor: a case report. This evidence concerns the gene BRCA2 and follicular dendritic cell sarcoma.